Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Jahn, S; Zollner, G; Lackner, C; Stauber, RE.
Severe toxic hepatitis associated with dronedarone.
Curr Drug Saf. 2013; 8(3):201-202
Doi: 10.2174/15748863113089990031
(- Case Report)
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Jahn Stephan
- Stauber Rudolf
- Co-Autor*innen der Med Uni Graz
- Lackner Karoline
- Zollner Gernot
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Dronedarone was introduced in 2009 as a new antiarrhythmic agent and since then has been increasingly prescribed in atrial fibrillation or flutter. To date, two cases of severe toxic hepatitis have been reported in patients treated with dronedarone, both requiring emergency liver transplantation, and the FDA as well as the EMA have issued warnings about possible severe hepatotoxicity of dronedarone. Here we report an additional case of toxic hepatitis associated with dronedarone presenting with acute liver failure, followed by spontaneous recovery, in a 69-year old woman.
- Find related publications in this database (using NLM MeSH Indexing)
- Aged -
- Amiodarone - adverse effects Amiodarone - analogs & derivatives Amiodarone - therapeutic use
- Anti-Arrhythmia Agents - adverse effects Anti-Arrhythmia Agents - therapeutic use
- Atrial Fibrillation - drug therapy
- Drug-Induced Liver Injury, Chronic - etiology Drug-Induced Liver Injury, Chronic - physiopathology
- Female -
- Humans -
- Severity of Illness Index -